CN
593-39-5
应用筛选条件
关键词:'593-39-5'
显示 1-30 共 35 条结果 关于 "593-39-5" 范围 技术文档
XP725 Antibody Number-Lot Number 071M4826
25 26 27 28 49 50 51 52 73 74 75 76
1.2 5 6 7 8 29 30 31 32 53 54 55 56 77 78 79 80
1.3 9 10 11 12 33 34 35 36 57 58 59 60
Product Information Sheet - P5147
Biochem., 48(4), 593-602
(1960).
3. Jurášek, L. et al., Can. J. Biochem., 49(11),
1195-1201 (1971).
4. Johnson, P., and Smillie, L.B., FEBS Lett., 47(1),
1-6 (1974).
5. Jurášek, L. et
Novabiochem Letters 02/06
America +50 2 2277 2222
Chile +56 2 3400 000
China +86 21 3222 4788
Colombia +57 1 425 4770
Ecuador +593 2 2981677
Guatemala See Central America
Hong Kong +852 2757 7569
India +91 22 5660 9184
Indonesia +
Publication Microbiology: An evaluation of a new chromogenic / flourogenic microbiology media system
N. (1993) Use of 5-bromo-4-
chloro-3-indolyl-ß-D-galactopyranoside for the isolation of ß-D-galactosidase-positive bacteria
from municipal water supplies. Can. J. Microbiol. 39, 821-825.
S100B as a Biomarker for Ca<sup>2+</sup> Signaling Dysregulation in Schizophrenia White Paper
schizophrenia. A critical
review of the data and their interpretation. Brain. 1999; 122
(Pt 4): 593-624.
10. Iritani, S. Neuropathology of schizophrenia: a mini review.
Neuropathology. 2007; 27:
QIA61 TGFα- ELISA Kit QIA61
Katoh, M., et al. 1990. Biochem. Biophys. Res. Commun. 167, 1065.
Derynck, R., 1988. Cell 54, 593.
Coffey, R.J., et al. 1987. Nature 328, 817.
Yeh, Y.C., et al. 1987. Cancer Res. 47, 896.
Derynck
Quantitative determination of total coliforms and Escherichia coli in marine waters with chromogenic and fluorogenic media
(1993) Use of 5-bromo-4-chloro-3-indolyl-b-D-galactopiranoside
for the isolation of b-galactosidase-positive bacteria from munici-
pal water supplies. Canadian Journal of Microbiology 39, 821–825.
Manafi
ApopTag® Fluorescein Direct In Situ Apoptosis Detection Kit
J. Pathol. 136: 593-608.
4. Attanasio, A. and D. Schiffer. (1995) Ultrastructural detection of DNA
strand breaks by in situ end-labelling techniques. J. Pathol. 176:27-35.
5. Brown, D.G., X.
ApopTag® Red In Situ Apoptosis Detection Kit
J. Pathol. 136: 593-608.
4. Attanasio, A. and D. Schiffer. (1995) Ultrastructural detection of DNA
strand breaks by in situ end-labelling techniques. J. Pathol. 176:27-35.
5. Brown, D.G., X.
ApopTag® Peroxidase In Situ Oligo Ligation (ISOL) Apoptosis Detection Kit
. J. Pathol. 136: 593-608.
4. Attanasio, A., and Schiffer, D. (1995) Ultrastructural detection of DNA
strand breaks by in situ end-labeling techniques. J. Pathol. 176:27-35.
5. Brown, D.G., Sun
ApopTag® Peroxidase In Situ Apoptosis Detection Kit
J. Pathol. 136: 593-608.
4. Attanasio, A. and D. Schiffer. (1995) Ultrastructural detection of DNA
strand breaks by in situ end-labelling techniques. J. Pathol. 176:27-35.
5. Brown, D.G., X.
Corticotropin-Releasing Factor Receptor Antagonists- Potential Novel Therapies for Human Disease
Endocrinology, 139, 3357-3360 (1998).
124. McGrath, S. and Smith, R., Clin. Endocrinol. (Oxf), 55, 593-595 (2001).
125. McLean, M. and Smith, R., Reproduction, 121, 493-501 (2001).
126. Karteris, E., et
Brochure: LC-MS Contaminants
1600 1800 m/z
x105
M
S
in
te
ns
it
y
63
.5
10
5.
2
22
7.
0
29
3.
1
39
9.
1
45
7.
0
53
9.
0
64
5.
0
M
S
ApopTag® Plus Peroxidase In Situ Apoptosis Detection Kit
J. Pathol. 136: 593-608.
4. Attanasio, A. and D. Schiffer. (1995) Ultrastructural detection of DNA
strand breaks by in situ end-labelling techniques. J. Pathol. 176:27-35.
5. Brown, D.G., X.
LC-MS Contaminants: Avoid, identify, mimimize.
1600 1800 m/z
x105
M
S
in
te
ns
it
y
63
.5
10
5.
2
22
7.
0
29
3.
1
39
9.
1
45
7.
0
53
9.
0
64
5.
0
M
S
Antibody SourceBook, Sixth Edition, DIST version
Goat Anti-Human IgG, g-Chain Specific Peroxidase Conjugate �01��5 2 ml €153
Goat Anti-Human IgG, Fc Fragment Specific �01�39 5 ml €89
Goat Anti-Human IgG, H & L Chain F(ab’)2 Fragment Peroxidase
Advanced Applications of Engineered Nanomaterials
nanopowder ���8��
39 Y Yttrium(III) oxide 25-30 nanopowder 5��89�
Yttrium(III) oxide 99.9+% 5% dispersion in water ��1901
40 Zr Zirconium(IV) oxide 25-30 nanopowder 5��7�0
Zirconium(IV)
Calbiochem Biologics 32.4
560 nmol/min/mg
protein. Purity: ≥90% by SDS-PAGE
Cat. No. 539686 5 mg € 93
Ref.: Hausser, A ., et al . 2001 . FEBS Lett. 492, 39; Hausser, A ., et al . 1999 . J. Biol. Chem.
274, 9258;
Diabetes and Obesity
: +57 1 425 5407
E-mail: mcsa@merck.com.co
www.merck.com.co
Ecuador
Merck C.A.
Tel: +593 2 2981677
Fax: +593 2 2981644
E-mail: sicmerck@merck.com.ec
www.merck.com.ec
Guatemala
Merck Centroamericana
Calbiochem Biologics 32.2
NMR and HPLC. M.W. 420.4
Cat. No. 344101 5 mg € 167
Ref.: Higuchi, M., et al. 2005. Nat. Neurosci. 8, 527; Sato, K., et al. 2004. Eur. J. Med.
Chem. 39, 573.
β-Secretase Inhibitor IV
A cell-permeable
Cytoskeletal Signaling Antibodies, Reagents and Kits
Dystroglycan
Monoclonal Antibody
Anti-α-Dystroglycan IIH6C4 H M R Gp WB IH Ascites M IgM 200 µL 05-593
Rb Ca
Anti-α-Dystroglycan VIA4-1 H M R Gp WB IH Sup M IgG1 200 µL 05-298
Rb Ca
Cranin
Protein Purification and Detection Tools
: +57 1 425 5407
E-mail: mcsa@merck.com.co
www.merck.com.co
Ecuador
Merck C.A.
Tel: +593 2 2981677
Fax: +593 2 2981644
E-mail: sicmerck@merck.com.ec
www.merck.com.ec
Guatemala
Merck Centroamericana
Filters and Supporting Hardware
Whatman® filter paper
Flat grade 589/3 591 595 597 597 L 598 602 h 602 eh
Prepleated (Folded) grade 593½ 594½ 595 ½ 597 ½ 598 ½ 602 h½ 604 ½
Particle type
Coarse particles X
Medium
XP725 Antibody List Lot 129K4831
002574.2 y y y
558 Proliferating Cell Nuclear Antigen (PCNA) P8825 5111 PCNA M NP_002583.1 y n/d n/d
593 Platelet-Derived Growth Factor Receptor ? P7679 5159 PDGFRB M NP_002600.1 y n/d n/d
559 PDK 1 P3110
XP725 Antibody List Lot 129K4830
002574.2 y y y
558 Proliferating Cell Nuclear Antigen (PCNA) P8825 5111 PCNA M NP_002583.1 y n/d n/d
593 Platelet-Derived Growth Factor Receptor ? P7679 5159 PDGFRB M NP_002600.1 y n/d n/d
559 PDK 1 P3110
XP725 Antibody List Lot 089K4791
002574.2 y y y
558 Proliferating Cell Nuclear Antigen (PCNA) P8825 5111 PCNA M NP_002583.1 y n/d n/d
593 Platelet-Derived Growth Factor Receptor ? P7679 5159 PDGFRB M NP_002600.1 y n/d n/d
559 PDK 1 P3110
Halal Certificate
FG W243434 A22264 HC-23SIZH98
592. ETHYL HEPTANOATE 98%, FCC, FG W243701 B26223 HC-23SIC535
593. ETHYL HEXANOATE 98%, FCC, FG W243906 A77129 HC-23SIRV69
594. ETHYL HEXANOATE NATURAL, 98%, FCC
Halal Certificate
FG W243434 A22264 HC-22SI9C20
592. ETHYL HEPTANOATE 98%, FCC, FG W243701 B26223 HC-22SI7H56
593. ETHYL HEXANOATE 98%, FCC, FG W243906 A77129 HC-22SI8W90
594. ETHYL HEXANOATE NATURAL, 98%, FCC
Chrombook (WEB-Version)
µL
250 x 2 0.25 mL/min ≈ 0.2 mg 0.2 - 5 µL
250 x 3 0.6 mL/min ≈ 1 mg 1 - 20 µL
250 x 4 1 mL/min ≈ 5 mg 5 - 80 µL
250 x 10 6 mL/min ≈ 30
MAPK: Antibodies, Proteins, Kits, siRNA and Reagents
-B PA 10 µg 14-620
LMPTP-A PA 10 µg 14-619
PTPMEG-1 PA 10 µg 14-642
HePTP KA Pur 10 µg 14-593
TCPTP PA 10 µg 14-646
PTP-1D
see SHP-2 below
Rac
Rac is a member of
1/2